Evidence map›Paper›PMID 36015318›Full record

ArticlePharmaceutics2022

Antiproliferative Copper(II) Complexes Bearing Mixed Chelating Ligands: Structural Characterization, ROS Scavenging, In Silico Studies, and Anti-Melanoma Activity.

Rodica Olar, Catalin Maxim, Mihaela Badea, Mihaela Bacalum, Mina Raileanu, Speranta Avram, Nataša Čelan Korošin, Teodora Burlanescu, Arpad Mihai Rostas

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Rodica OlarFaculty of Chemistry, Department of Inorganic Chemistry, University of Bucharest, 90-92 Panduri Str., 050663 Bucharest, Romania.ORCID 0000-0002-4208-0972
Catalin MaximFaculty of Chemistry, Department of Inorganic Chemistry, University of Bucharest, 90-92 Panduri Str., 050663 Bucharest, Romania.ORCID 0000-0001-6033-3710
Mihaela BadeaFaculty of Chemistry, Department of Inorganic Chemistry, University of Bucharest, 90-92 Panduri Str., 050663 Bucharest, Romania.ORCID 0000-0002-4018-7610
Mihaela BacalumHoria Hulubei National Institute for Physics and Nuclear Engineering, Department of Life and Environmental Physics, 30 Reactorului Str., 077125 Magurele-Ilfov, Romania.ORCID 0000-0002-7309-6002
Mina RaileanuHoria Hulubei National Institute for Physics and Nuclear Engineering, Department of Life and Environmental Physics, 30 Reactorului Str., 077125 Magurele-Ilfov, Romania.
Speranta AvramFaculty of Biology, Department of Anatomy, Animal Physiology and Biophysics, University of Bucharest, 91-95, Splaiul Independenței, 050095 Bucharest, Romania.
Nataša Čelan KorošinFaculty of Chemistry and Chemical Technology, University of Ljubljana, Večna pot 113, 1000 Ljubljana, Slovenia.ORCID 0000-0002-1484-5165
Teodora BurlanescuLaboratory of Optical Processes in Nanostructure Materials, National Institute of Materials Physics, 405A Atomiștilor Str., 077125 Magurele-Ilfov, Romania.
Arpad Mihai RostasLaboratory of Atomic Structures and Defects in Advanced Materials, LASDAM, National Institute of Materials Physics, 405A Atomiștilor Str., 077125 Magurele-Ilfov, Romania.ORCID 0000-0001-8190-9512
University of Bucharest · RONational Institute of Materials Physics · ROHoria Hulubei National Institute for R and D in Physics and Nuclear Engineering · ROUniversity of Ljubljana · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melanoma is a skin cancer characterized by rapid growth and spread for which current therapies produce both resistance and increased risk of infection. To develop new anti-melanoma biocompatible species, the series of complexes Cu(N-N)(bzac)(X)⋅nH

Indexed as

ADME-ToxbioinformaticsCu(II) complexcytotoxicitymelanoma cellsROSstructure

Identifiers

PMID36015318
PMCPMC9416163
OpenAlexW4291512465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.